These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 19915359
1. [Progress in the molecular analysis of infant leukemias]. Ishii E. Rinsho Ketsueki; 2009 Oct; 50(10):1500-5. PubMed ID: 19915359 [No Abstract] [Full Text] [Related]
2. Expression of NG2 antigen in MLL-rearranged acute leukemias: how complex does it get? Menendez P, Bueno C. Leuk Res; 2011 Aug; 35(8):989-90. PubMed ID: 21492935 [No Abstract] [Full Text] [Related]
3. HRX gene rearrangement in secondary acute lymphoblastic leukemia. Kobayashi Y, Hayashi Y, Ozawa K, Asano S. Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829 [Abstract] [Full Text] [Related]
4. Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment. Jung R, Jacobs U, Krumbholz M, Langer T, Keller T, De Lorenzo P, Valsecchi MG, van der Velden VH, Moericke A, Stanulla M, Teigler-Schlegel A, Panzer-Gruemayer ER, van Dongen JJ, Schrappe M, den Boer ML, Pieters R, Rascher W, Metzler M. Leukemia; 2010 Apr; 24(4):903-7. PubMed ID: 20164851 [No Abstract] [Full Text] [Related]
5. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhães IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF. Cancer Res; 2001 Mar 15; 61(6):2542-6. PubMed ID: 11289128 [Abstract] [Full Text] [Related]
6. Early-age Acute Leukemia: Revisiting Two Decades of the Brazilian Collaborative Study Group. Pombo-de-Oliveira MS, Andrade FG, Brazilian Collaborative Study Group of Infant Acute LeukaemiaPediatric Hematology-Oncology Research Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.. Arch Med Res; 2016 Nov 15; 47(8):593-606. PubMed ID: 28476187 [Abstract] [Full Text] [Related]
8. Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement. Kubicka M, Soszynska K, Mucha B, Rafinska B, Kolodziej B, Haus O, Styczynski J. Leuk Lymphoma; 2007 Oct 15; 48(10):2083-6. PubMed ID: 17917979 [No Abstract] [Full Text] [Related]
9. Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia. Millot F, Brizard F, Sorel N, Preudhomme C, Cividin M, Guilhot F, Brizard A. Leuk Lymphoma; 2005 Jun 15; 46(6):925-7. PubMed ID: 16019540 [Abstract] [Full Text] [Related]
10. Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach. Binato R, Meyer C, Macedo-Silva ML, Garcia D, Figueiredo A, Hofmann J, Vieira TP, Abdelhay E, Marschalek R. Cancer Lett; 2013 Sep 28; 338(2):249-54. PubMed ID: 23562474 [Abstract] [Full Text] [Related]
11. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II. Mosad E, Abdou M, Zaky AH. Oncology; 2012 Sep 28; 83(3):128-34. PubMed ID: 22814291 [Abstract] [Full Text] [Related]
12. Fatal Acute Myeloid Leukemia With 11q23 MLL Gene Rearrangement Following Mitoxantrone Treatment in a Case of Childhood-onset Multiple Sclerosis. Patejdl R, Krohn S, Murua Escobar H, Zettl UK. J Pediatr Hematol Oncol; 2015 Jul 28; 37(5):413-4. PubMed ID: 25851557 [No Abstract] [Full Text] [Related]
14. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy. Larish AM, Dolan M, Casey T, Perkins JL. J Pediatr Hematol Oncol; 2015 May 28; 37(4):e215-7. PubMed ID: 25493458 [Abstract] [Full Text] [Related]
15. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature. Fournier E, Inchiappa L, Delattre C, Pignon JM, Danicourt F, Bemba M, Roche-Lestienne C, Daudignon A, Decool G, Roumier C, Dumezy F, Fournier L, Grardel N, Preudhomme C, Duployez N. Leuk Lymphoma; 2019 Jul 28; 60(7):1827-1830. PubMed ID: 30616415 [No Abstract] [Full Text] [Related]
16. Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research. Pelkonen O, Terron A, Hernandez AF, Menendez P, Bennekou SH, EFSA WG EPI1 and its other members. Arch Toxicol; 2017 Aug 28; 91(8):2763-2780. PubMed ID: 28536863 [Abstract] [Full Text] [Related]
17. Topoisomerase II and the etiology of chromosomal translocations. Felix CA, Kolaris CP, Osheroff N. DNA Repair (Amst); 2006 Sep 08; 5(9-10):1093-108. PubMed ID: 16857431 [Abstract] [Full Text] [Related]
20. Challenges in the use of NG2 antigen as a marker to predict MLL rearrangements in multi-center studies. Emerenciano M, Renaud G, Sant'Ana M, Barbieri C, Passetti F, Pombo-de-Oliveira MS, Brazilian Collaborative Study Group of Infant Acute Leukemia. Leuk Res; 2011 Aug 08; 35(8):1001-7. PubMed ID: 21444110 [Abstract] [Full Text] [Related] Page: [Next] [New Search]